Korean digital health company LifeSemantics has obtained the first approval for an AI-powered solution for skin cancer diagnosis in South Korea.
The company received regulatory clearance from the Ministry of Food and Drug Safety for canofyMD SCAI four months after its application.
The mobile AI technology was developed through the Doctor Answer 2.0 project, which has gathered 30 hospitals and 19...
Researchers from the faculties of Engineering and IT at Monash University have come up with an AI algorithm that can judge another AI algorithm's annotation or label in a medical scan, mimicking the process of seeking a second opinion.
FINDINGS
They created a dual-view AI system where one part labels medical images while the other judges the quality of the AI-generated labelled scans by...
A new AI model for diagnosing sleep apnea has been developed by a research team at Seoul National University Bundang Hospital.
The deep learning model analyses cephalograms, focusing on the tongue and its surrounding structures, which are highly associated with sleep apnea.
Based on a press statement, the model was developed using head and neck x-ray image data of 5,591 patients at SNUBH. It was...
South Korean medtech firm Coreline Soft has obtained the United States Food and Drug Administration's 510(k) clearance for its latest AI-powered analysis software for screening lung nodules.
The company develops AI imaging solutions for diagnosing various chest conditions, aortic disease, spinal disease, and metastatic cancer in the chest.
WHAT IT DOES
Its latest software-as-a-medical device...
Indian biotech company Mylab Discovery Solutions is integrating Qure.ai's AI technology into its upcoming x-ray device for screening tuberculosis.
According to a press statement, MyBeam is a compact, lightweight device equipped with high-frequency technology for detecting TB. It will be powered by Qure.ai's deep-learning software qXR to analyse chest x-ray images and identify TB within a minute...
Health charity Skin Check Champions, the University of South Australia, and The Hospital Research Foundation have teamed up to launch a pop-up clinic that uses AI to diagnose skin cancer.
Their pop-up clinic is led by nurses who take high-quality lesion images from patients, which are then triaged and conditionally diagnosed by AI algorithms to check if they are cancerous. The results are also...
Singapore clears VUNO's AI software for fundus analysis
South Korean medical AI firm VUNO has recently obtained a medical device certification from Singapore's Health Sciences Authority for its AI-based fundus analysis software.
The VUNO Med-Fundus AI analyses images of the fundus, which is the back part of the eye, to provide findings necessary for the diagnosis of retinal diseases. It can...
Oncoshot receives funding to further expand in India, Australia
Singaporean medical startup Oncoshot has scored an undisclosed investment through a pre-Series A funding round led by Biofurmis and Qure.ai investor MassMutual Ventures.
Based on a press release, the funding will support the company's further expansion into India and Australia.
There are four hospital networks in India and some...
Australia-listed medtech firm Artrya has disclosed that its subsidiary in the United States has signed a clinical partnership with Alabama-based Huntsville Heart Center.
According to a media release, an initial agreement between the companies involves a study to determine the efficacy of Artrya's AI technology for diagnosing coronary heart disease.
WHY IT MATTERS
The Artrya Salix is an AI-powered...
Lunit gets first go-ahead for South Korea IPO
AI startup Lunit has received preliminary approval from the Korea Exchange for its initial public offering on the KOSDAQ.
This comes five months after it raised $61 million in a fundraising event that was held to seek global partners.
In a recent statement, Lunit said it plans to file its registration statement within the first half of 2022 to...
